Akers Biosciences Inc (AKR)

 

Latest News

Akers Bio offering increased

Akers Biosciences says proceeds from its offering announced on 10 January are now expected to increase to $2,147,400, gros...

Issue of Equity

RNS Number: 0800U Akers Biosciences, Inc. 13 January 2017 13 January 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ( " Akers Bio " or the "Company"), a developer of rapid health information technologies, announces that, further to the public offering announce...

Issue of Equity

RNS Number: 7349T Akers Biosciences, Inc. 10 January 2017 10 January 2017 This announcement contains inside information Akers Biosciences, Inc. Filing of Supplement to Form S-3 Registration Statement Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ( " Akers Bio " or the "Company"), a developer of rapid health information technologies,...

Supplement to Form S-3 Registration Statement

RNS Number: 6004T Akers Biosciences, Inc. 09 January 2017 9 January 2017 This announcement contains inside information Akers Biosciences, Inc. Filing of Supplement to Form S-3 Registration Statement Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (" Akers Bio " or the "Company"), a developer of rapid health information technologies, announces that ...

All News

DateHeadlineSource
13-01-17Akers Bio offering increased StockMarketWire
13-01-17Issue of EquityRNS
10-01-17Issue of EquityRNS
09-01-17Supplement to Form S-3 Registration StatementRNS
20-12-16Akers Bio resolutions passed at AGMStockMarketWire
19-12-16Result of AGMRNS
19-12-16Agreement with GNYHA for PIFA Heparin PF4 TestRNS
01-12-16US Distribution Agreement: Cholesterol Self-testRNS
28-11-16Akers Bio completes BreathScan DKA trial StockMarketWire
28-11-16Clinical Trial for BreathScan DKA CompletedRNS
14-11-16Notice of AGMRNS
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-163rd Quarter ResultsRNS
10-11-16Akers Bio schedules Q3 results StockMarketWire
10-11-16Akers Bio granted European patentStockMarketWire
10-11-16European Patent GrantedRNS
09-11-16Notice of Q3 ResultsRNS
25-10-16Filing of Form S-3 Registration StatementRNS
19-08-16Akers Bio settles dispute with ChubeWorkxStockMarketWire
19-08-16Settlement of Dispute with ChubeWorkxRNS
18-08-16Akers Bio excited about OxiChek results StockMarketWire
18-08-16Results of OxiChek Test StudyRNS
11-08-16Akers Bio gross profits up 34%StockMarketWire
11-08-16Half Yearly ResultsRNS
09-08-16Notice of H1 2016 EarningsRNS
30-06-16Akers Bio completes clinical trial for Chlamydia testStockMarketWire
30-06-16Clinical Trial for Rapid Chlamydia Test CompletedRNS
27-06-16Akers distribution deal for OxiChekStockMarketWire
27-06-16Distribution Agreement for BreathScan OxiChekTRNS
17-06-16Broker Forecast - finnCap issues a broker note on Akers Biosciences IncStockMarketWire
14-06-16Issue of Equity & PDMR ShareholdingRNS
26-05-16PDMR ShareholdingRNS
12-05-16Akers Bio product revenue up 79%StockMarketWire
12-05-16Financial Results for Q1 2016RNS
10-05-16Akers Bio schedules Q1 resultsStockMarketWire
10-05-16Notice of Q1 ResultsRNS
25-04-16Board changes at Akers BiosciencesStockMarketWire
25-04-16Board RearrangementRNS
30-03-16Akers Bio's lossStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory